Intrahospital Vaccination and Counseling to Increase Seasonal Influenza Immunization
in Patients at High Cardiovascular Risk in Germany
The Randomized Controlled VACC-UP Study
Led by Stephan Baldus · Updated on 2026-10-13
482
Participants Needed
2
Research Sites
65 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effect of offering influenza vaccination during hospital stays alongside active counseling for adults hospitalized with acute coronary syndrome ACS or congestive heart failure CHF. The study compares this approach to active counseling alone to see if it improves flu vaccination rates among patients at high cardiovascular risk.
Participants are randomly assigned to one of two groups. One group receives standardized counseling plus an offer of bedside influenza vaccination during their hospital stay, following German vaccination guidelines, including specific vaccine types based on age. The other group receives the same counseling but only a discharge recommendation for ambulatory vaccination, without intrahospital vaccination. Vaccinations are offered from September 1 to February 28 during the influenza season.
During the study, participants complete questionnaires and receive counseling before randomization. Researchers track vaccination rates up to the end of the influenza season in March. Additional measures include patient satisfaction with vaccination offers and psychological factors related to vaccination decisions. The study lasts up to about seven months per participant, with follow-up extending to the next influenza season for some outcomes.
CONDITIONS
Brief Title
Intrahospital Influenza Vaccination in Patients at High Cardiovascular Risk (VACC-UP)
Research Team
S
Sebastian Heyne, Dr. med.
S
Stephan Baldus, Prof. Dr. med.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Hospitalized due to acute coronary syndrome (ACS) or congestive heart failure (CHF) and meet vaccination criteria per German STIKO recommendations
Able to provide written informed consent
You will not qualify if you...
Already received seasonal influenza vaccination in the current season
Laboratory-confirmed active influenza infection during hospitalization
Contraindication to vaccination, such as known allergy
Unable to provide written informed consent
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Up to approximately 7 months until the end of the influenza season (March 31)
Participants receive standardized active counseling and either an offer of bedside influenza vaccination during hospitalization or a recommendation for ambulatory vaccination at discharge.
Visits during hospitalization and follow-up assessments
Follow-up
Duration - Up to approximately 19 months
Researchers assess influenza vaccination rates, patient satisfaction, and psychological factors related to vaccination decisions up to the end of the post-index influenza season, about 19 months after randomization.
Follow-up assessments at scheduled intervals
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Similar Trials
Risk Prediction Study for Patients with Structural, Rhythm, or Inflammatory Cardiovascular Diseases
Study of Perfect Heartio Drink to Support Heart and Blood Vessel Health in Adults
Early Detection of Type 2 Diabetes and Cardiovascular Risks Using CUORE and FINDRISC Tools in Adults Turning 50 in Marche Region
100-Year Human Aging Study Observing Multi-System Health to Predict Mortality and Aging Outcomes
Phase 2 Study of 18F-mFBG PET Imaging
for Heart Failure Patients with Ischemic Cardiomyopathy
and Implantable Cardioverter-Defibrillators
Post-Discharge Counseling and Phone Follow-Up to Reduce Heart Failure Readmissions at Komfo Anokye Teaching Hospital
Myocardial Energetic Profiling Using 31P Magnetic Resonance Spectroscopy
and Prognostic Assessment Across Heart Failure and Cardiomyopathy Types
3D Imaging Study of Right Heart Function During Mechanical Pump Placement for Heart Failure
Evaluating Cardiac Fibrosis in Heart Failure Using 68Ga-FAPI PETCT Compared to MRI
A Pilot Study in Patients with HFrEF and HFpEF
Study of Vascular Function and Exercise Effects in Aging and Cardiovascular Diseases Including COPD and Pulmonary Hypertension
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial.
David S Lawrence, Charles Muthoga, David B Meya...